James C. Kudrna, M.D., Ph.D.

James C. Kudrna, M.D., Ph.D.

James C. Kudrna, M.D., Ph.D.

Log into NorthShoreConnect

Profile

Personal Bio

Treatment Philosophy

My focus over three plus decades has been on, individualized, compassionate and comprehensive care for adult hip patients.

Personal Interests

In my free time my passion is fly fishing.

Conditions & Procedures

Conditions

Procedures

Hip Resurfacing Arthroplasty, Reconstructive Hip Surgery

General Information

Gender

Male

Affiliation

NorthShore Medical Group

Expertise

Adult Hip Diseases, Reconstructive Hip Surgery, Hip Resurfacing Arthroplasty

Academic Rank

Clinical Associate Professor

Languages

English

Board Certified

Orthopaedic Surgery

Clinical Service

Education, Training & Fellowships

Medical School

Northwestern Feinberg School of Medicine, 1976

Internship

Northwestern Feinberg School of Medicine

Residency

Northwestern Feinberg School of Medicine

Locations

A

NorthShore Medical Group

9650 Gross Point Rd.
Suite 2900
Skokie, IL 60076
847.866.7846 224.251.2905 fax This location is wheelchair accessible.

Insurance

Commercial Plans
  • Aetna Choice POS (Open Access) and POS II (Open Access)
  • Aetna Elect Choice EPO and EPO Open Access
  • Aetna Health Network Options
  • Aetna HMO (including Open Access)
  • Aetna Managed Choice (Open Access)
  • Aetna Managed Choice POS
  • Aetna Open Access Aetna Select (Aetna HealthFund)
  • Aetna Open Access Elect Choice EPO (Aetna HealthFund)
  • Aetna Open Access Managed Choice POS (Aetna HealthFund)
  • Aetna Open Choice PPO
  • Aetna Open Choice PPO (Aetna HealthFund)
  • Aetna Premier Care Network
  • Aetna QPOS
  • Aetna Select
  • Aetna Select (Open Access)
  • Beechstreet PPO Network
  • Blue Cross Blue Shield - PPO Products
    Not Contracted Blue Cross Blue Shield Blue Choice PPO
  • Blue Cross Blue Shield Blue Advantage
    Verify PCP Participation
  • Blue Cross Blue Shield HMOI
  • Cigna HMO
  • Cigna LocalPlus
  • Cigna Open Access Plus (OAP)
  • Cigna Open Access Plus with CareLink (OAPC)
  • Cigna POS
  • Cigna PPO
  • Cofinity PPO (an Aetna Company)
  • Coventry Health Care Elect Choice EPO
  • Coventry Health Care First Health PPO
  • Galaxy Health PPO Network
  • Great West PPO/POS
  • Healthcare's Finest Network (HFN)
  • Humana - All Commercial Plans (including Choice Care)
  • Humana - NorthShore Complete Care
  • Humana/ChoiceCare Network PPO
  • Medicare
  • Multiplan and PHCS PPO Network (Including PHCS Savility)
  • NorthShore Employee Network I (EPO)
  • NorthShore Employee Network II (EPO Plus & CDHP)
  • Preferred Plan PPO
  • Three Rivers Provider PPO Network (TRPN)
  • Tricare
  • Unicare
  • United Healthcare - All Commercial Plans
    Not Contracted United Healthcare Core
    Not Contracted United Healthcare Navigate
Exchange Plans
  • Not Contracted Aetna
  • Blue Cross Blue Shield - PPO Products
    Not Contracted Blue Cross Blue Shield Blue Choice PPO
  • Blue Cross Blue Shield Blue Precision
    Verify PCP Participation
  • Not Contracted Coventry
  • Humana National
  • Land of Lincoln - All Products
  • Not Contracted United Healthcare Compass
Medicaid
  • Illinois Department of Public Aid (IDPA)
  • Illinicare ICP
  • Community Care Partners
Medicare Advantage Plans
  • Aetna Medicare (SM) Plan (HMO/Open Access HMO)
  • Aetna Medicare (SM) Plan (PPO)
  • Blue Cross Blue Shield Medicare Advantage PPO Plan
    Effective 1/1/2015
  • Cigna-HealthSpring Advantage HMO
  • Cigna-HealthSpring Premier HMO-POS
  • Cigna-HealthSpring Primary HMO
  • Humana Gold Plus HMO
  • Humana Gold Plus PFFS
  • HumanaChoice PPO
  • United Healthcare - All Medicare Plans
Medicare Medicaid Alignment Initiative (MMAI) Plans
  • Blue Cross Blue Shield Community
  • HealthSpring
  • Humana
  • Illinicare Health Plan
  • Meridian Complete

Publications

  • Are metal ion levels a useful trigger for surgical intervention?

    The Journal of arthroplasty 2012 Sep

    Authors: Griffin WL,
    Abstract
    The purpose of this study was to determine if cobalt and chromium ion levels can predict soft tissue damage at total hip revision. This study included 90 metal-on-metal total hip patients with preoperative cobalt and chromium ion levels. Tissue damage noted at revision surgery was graded on a 4-point scale. Sensitivity, specificity, and predictive values were calculated for various threshold values. Receiver operating characteristic analysis was conducted. Using 7 ppb as a threshold, cobalt and chromium ion levels had poor sensitivity and specificity (Co, 65% and 56%; Cr, 29% and 75%). Positive predictive values for cobalt and chromium were only 48% and 26% respectively. The area under the curve was 0.37 for cobalt and 0.44 for chromium. The length of time to revision significantly correlated with tissue damage (P = .001). Ion levels are unreliable predictors of periarticular soft tissue damage and should not be used in isolation as surgical intervention triggers.
    PMID: 22608683 [PubMed - as supplied by publisher]
  • Staphylococcus aureus nasal decolonization in joint replacement surgery reduces infection.

    Clinical orthopaedics and related research 2008 Jun

    Authors: Hacek DM,
    Abstract
    Surgical site infections (SSIs) with Staphylococcus aureus are a recognized adverse event of hip and knee replacements. We evaluated the impact of a program to detect S. aureus nasal carriers before surgery with preoperative decolonization (using mupirocin twice daily for 5 days prior to surgery) of carriers. Nasal swab samples were obtained from patients prior to surgery from 8/1/2003 through 2/28/2005. Samples were tested using real-time PCR technology to detect S. aureus. The group that developed S. aureus SSI was compared to a combined concurrent and historical control for one year following the operation. S. aureus caused 71% of SSIs in the combined control groups. Of the 1495 surgical candidates evaluated, 912 (61.0%) were screened for S. aureus; 223 of those screened (24.5%) were positive and then decolonized with mupirocin. Among the 223 positive and decolonized patients, three (1.3%) developed a SSI. Among the 689 screen-negative patients, four (0.6%) developed SSIs for an overall rate of 0.77%. Among the 583 control patients who were not screened or decolonized, 10 (1.7%) developed S. aureus SSIs. SSIs from other organisms were 0.44% and 0.69%, respectively.
    Level III, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.
    PMID: 18347889 [PubMed - as supplied by publisher]
  • Venous thromboembolism following major orthopedic surgery: what is the risk after discharge?

    Orthopedics 2006 Jun

    Authors: Arcelus JI,
    Abstract
    Guidelines recommend thromboprophylaxis for at least 10 days to prevent venous thromboembolism in patients undergoing high-risk orthopedic surgery, such as total hip arthroplasty (THA) or total knee arthroplasty (TKA). Furthermore, the recently updated ACCP guidelines also recommend extending the duration of thromboprophylaxis for 28 to 35 days following THA or hip fracture surgery as the risk for venous thromboembolism persists for up to 3 months after surgery. Extended-duration thromboprophylaxis (up to 6 weeks) with low-molecular-weight heparin is significantly more effective in preventing venous thromboembolism in orthopedic surgery patients than the recommended practice of at least 10 days. Extended-duration thromboprophylaxis may require risk stratification to identify high-risk patients. Current risk-assessment models have limitations and are not specific to orthopedic surgery patients; therefore, improvements may facilitate the use of extended-duration thromboprophylaxis in high-risk patients, thereby reducing the burden of venous thromboembolism.
    PMID: 16786943 [PubMed - as supplied by publisher]
  • Femoral version: definition, diagnosis, and intraoperative correction with modular femoral components.

    Orthopedics 2005 Sep

    Authors: Kudrna JC,
    Abstract
    Normal femoral version contributes to the inherent stability of the hip joint. Abnormal version is found in a variety of hip diseases afflicting children and adults. At the time of reconstruction for end-stage hip disease, maintaining proper femoral version in conjunction with acetabular version allows for hip stability and unimpeded functional range of motion. In those instances where femoral version is significantly abnormal, a means of correction at time of surgery is necessary. Non-modular femoral components allow for minor adjustments in version at time of surgery. To accommodate significant versional abnormalities, the modular S-ROM (DePuy Orthopaedics Inc, Warsaw, Ind) was introduced in 1984. In a series of 156 primary S-ROM total hip arthroplasties, the ability to correct for abnormal version resulted in excellent clinical results with no incidence of hip instability and excellent range of motion.
    PMID: 16190033 [PubMed - as supplied by publisher]
  • Early failure of a proximally cemented, distally uncemented total hip arthroplasty.

    The Journal of arthroplasty 2003 Oct

    Authors: Vora A,
    Abstract
    This investigation prospectively studied a consecutive series of 22 proximally cemented, distal cementless, femoral components with a minimum follow-up time of 24 months. The prosthesis was a titanium, proximally cemented, femoral component with a distal press-fit fluted design. Five hips (23%) developed aseptic mechanical loosening at an average of 46.2 months and required revision. The technique required excessive removal of cancellous bone leading to a suboptimal bone-cement interface. The early failure rates of this prosthesis are unacceptably high for a contemporary hip design. To the best of our knowledge, no clinical studies have reported on the stability and longevity of this new proximal cementing technique incorporated with a distal press-fit femoral design.
    PMID: 14566745 [PubMed - as supplied by publisher]
× Alternate Text